Optimization of amorphadiene synthesis in bacillus subtilis via transcriptional, translational, and media modulation.
暂无分享,去创建一个
Gregory Stephanopoulos | Kang Zhou | Heng-Phon Too | G. Stephanopoulos | H. Too | K. Zhou | R. Zou | Congqiang Zhang | Congqiang Zhang | Ruiyang Zou
[1] G. Stephanopoulos,et al. Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. , 2005, Metabolic engineering.
[2] Susan C. Roberts,et al. Pharmaceutically active natural product synthesis and supply via plant cell culture technology. , 2008, Molecular pharmaceutics.
[3] G. Stephanopoulos,et al. Engineering Yeast Transcription Machinery for Improved Ethanol Tolerance and Production , 2006, Science.
[4] T. Panavas,et al. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. , 2009, Methods in molecular biology.
[5] Jay D. Keasling,et al. High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli , 2009, PloS one.
[6] I. Maeda. Genetic modification in Bacillus subtilis for production of C30 carotenoids. , 2012, Methods in molecular biology.
[7] J. Keasling,et al. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.
[8] Kazuyuki Yoshida,et al. Carotenoid production in Bacillus subtilis achieved by metabolic engineering , 2009, Biotechnology Letters.
[9] W. Schumann,et al. Development of a strong intracellular expression system for Bacillus subtilis by optimizing promoter elements. , 2012, Journal of biotechnology.
[10] Keith E. J. Tyo,et al. Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.
[11] G. Stephanopoulos,et al. Novel reference genes for quantifying transcriptional responses of Escherichia coli to protein overexpression by quantitative PCR , 2011, BMC Molecular Biology.
[12] R. Larossa,et al. Chromosomal promoter replacement of the isoprenoid pathway for enhancing carotenoid production in E. coli. , 2006, Metabolic engineering.
[13] Mark A Eiteman,et al. Simultaneous utilization of glucose, xylose and arabinose in the presence of acetate by a consortium of Escherichia coli strains , 2012, Microbial Cell Factories.
[14] B. Seong,et al. N‐terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers , 2007, Protein science : a publication of the Protein Society.
[15] G. Stephanopoulos,et al. Metabolite Profiling Identified Methylerythritol Cyclodiphosphate Efflux as a Limiting Step in Microbial Isoprenoid Production , 2012, PLoS ONE.
[16] Junfeng Xue,et al. Enhancing Isoprene Production by Genetic Modification of the 1-Deoxy-d-Xylulose-5-Phosphate Pathway in Bacillus subtilis , 2011, Applied and Environmental Microbiology.
[17] John R. Haliburton,et al. Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. , 2011, Metabolic engineering.
[18] J. McCafferty,et al. Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression , 2004, BMC biotechnology.
[19] M. Ashiuchi,et al. Bacillus subtilis pgsE (Formerly ywtC) stimulates poly-γ-glutamate production in the presence of zinc. , 2011, Biotechnology and bioengineering.
[20] R. Fall,et al. Evidence of Isoprenoid Precursor Toxicity in Bacillus subtilis , 2011, Bioscience, biotechnology, and biochemistry.